— Know what they know.
Not Investment Advice

INVA Dividends

Innoviva, Inc.
1W: -1.6% 1M: -1.4% 3M: -3.2% YTD: +5.4% 1Y: +18.2% 3Y: +63.1% 5Y: +27.6%
$20.94
-0.11 (-0.52%)
Pre-Market: $21.33 (+0.39, +1.86%)
Weekly Expected Move ±3.5%
$19 $20 $21 $21 $22
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $1.5B mcap · 68M float · 1.19% daily turnover · Short 42% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 15.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.21 (down 99%), Innoviva, Inc. would be worth roughly what it owes.
Total debt $269.7M against a stock market value of $1.51B.
Distance to default 10.31 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $129.2M (short-term plus half of long-term), stock volatility 26.8%; Altman Z'' 9.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Dividend Overview

—%
Dividend Yield
$—
Annual Dividend
—%
Payout Ratio
—%
FCF Payout
0
Yr Increase Streak
3.35%
Buyback Yield
2.53%
Total Return
—%
Chowder Number

Annual Dividend History

Quarterly Payment History

Shareholder Returns: Dividends vs Buybacks

Full Payment History (5 payments)
Ex-DateAmountAdj. AmountYieldFrequency
2015-09-08 $0.2500 $0.2500 739.10% Quarterly
2015-06-10 $0.2500 $0.2500 562.69% Quarterly
2015-03-10 $0.2500 $0.2500 392.11% Quarterly
2014-11-21 $0.2500 $0.2500 374.24% Quarterly
2014-08-26 $0.2500 $0.2500 114.59% Quarterly
Stock Split History (1 splits)
DateRatioType
2014-06-03 1241:1000 stock-split

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms